retatrutide expanded access program eli lilly infiltrates anti-obesity market as Phase III trial for begins Eli Lilly Chose One 79-Year-Old

For many people, GLP-1 medications (which are prescribed to manage type 2 diabetes or for weight loss) are literally life-saving

Lilly said the 338-person retatrutide study also showed that the drug helped improve blood pressure and blood sugar levels

The compound helps the body break down fat cells and use them for energy

Avoid if You Have: Personal/family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN2) Severe GI disorders like gastroparesis Known hypersensitivity to ingredients Additionally, tirzepatide hasnt been studied extensively in: Women who are pregnant or breastfeeding Always undergo a comprehensive health review with your provider before switching

Patients taking GLP-1 medications may notice these symptoms overlap with other semaglutide side effects